Intrahepatic Cholangiocarcinoma  >>  gemcitabine  >>  Phase 3
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
gemcitabine / Generic mfg.
CRUK-ABC-02, NCT00262769: Gemcitabine With or Without Cisplatin in Treating Patients With Unresectable Locally Advanced or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors

Completed
3
324
Europe
cisplatin, CDDP, cis-diamminedichloroplatinum(II), cisplatinum, gemcitabine hydrochloride, Gemzar
University College, London, Eli Lilly and Company
Extrahepatic Bile Duct Cancer, Gallbladder Cancer
08/08
 
PRODIGE-12, NCT01313377 / 2008-004560-39: Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by Surgery

Completed
3
190
Europe
gemcitabine hydrochloride, oxaliplatin, clinical observation, adjuvant therapy, quality-of-life assessment
UNICANCER
Extrahepatic Bile Duct Cancer, Gallbladder Cancer, Liver Cancer
06/16
06/16
NCT00304135: Fluorouracil, Cisplatin, and Radiation Therapy or Gemcitabine and Oxaliplatin in Treating Patients With Nonmetastatic Biliary Tract Cancer That Cannot Be Removed By Surgery

Completed
2/3
34
Europe
cisplatin, gemcitabine hydrochloride, oxaliplatin
Federation Francophone de Cancerologie Digestive
Extrahepatic Bile Duct Cancer, Gallbladder Cancer, Liver Cancer
12/12
12/12

Download Options